key: cord-0959119-r1r1vxgf authors: Fasina, Folorunso O.; Salami, Mudasiru A.; Fasina, Modupe M.; Otekunrin, Olutosin A.; Hoogesteyn, Almira L; Hittner, James B. title: Test positivity – evaluation of a new metric to assess epidemic dispersal mediated by non-symptomatic cases date: 2021-05-25 journal: Methods DOI: 10.1016/j.ymeth.2021.05.017 sha: 51bba76f2226a4744d73067500e59ede9650a3dd doc_id: 959119 cord_uid: r1r1vxgf Epidemic control may be hampered when the percentage of asymptomatic cases is high. To estimate whether test positivity may assist in policy-making, it was explored in the first 60 to 90 epidemic days in six Latin American countries that reported their first COVID-19 case between February and March, 2020: Argentina, Bolivia, Chile, Cuba, Mexico, and Uruguay. Test positivity (TP) is the percentage of test-positive individuals recorded on a given day out of all individuals tested on the same day. The epidemic data of the country infected last (Uruguay) was first analyzed to evaluate TP as well as: (i) the daily ratio of secondary over primary infections (apparent reproductive ratio or ARR); (ii) tests conducted per million inhabitants (TPMI), (iii) the temporal data on the number of active cases (all test-positive cases minus deaths and recovered patients), and (iv) that of recovered patients. Later, significant patterns identified in the first step were assessed in the six countries. The Uruguayan data indicated that (i) TP was positively correlated with the ARR (r=.92, p<0.01); (ii) TP informed more than the ARR: while major data departures revealed by the ARR were also detected by TP, TP exhibited patterns not shown by ARR; and (iii) three temporal stages were observed, which differed from one another in both TP and TPMI medians (P<0.01) and, together, revealed a negative relationships between TPMI and TP. The six Latin American countries showed that TP was positively correlated with deaths/million inhabitants or DMI (r=.62, p<0.01). The temporal analysis of policies revealed four patterns: (1) low testing and high DMI, (2) high testing and low DMI; (3) an intermediate pattern, and (4) high testing and high DMI (where isolation was not pursued). Findings support the hypothesis that test positivity may inform as much as, if not more than classic metrics, such as the TPMI. If complemented with high-resolution geographical data, these indicators could inform policy-makers when and where epidemic control measures are or are not successful. . tested on the same day. The epidemic data of the country infected last (Uruguay) was first analyzed to evaluate TP as well as: (i) the daily ratio of secondary over primary infections (apparent reproductive ratio or ARR); (ii) tests conducted per million inhabitants (TPMI), (iii) the temporal data on the number of active cases (all test-positive cases minus deaths and recovered patients), and (iv) that of recovered patients. Later, significant patterns identified in the first step were assessed in the six countries. The Uruguayan data indicated that (i) TP was positively correlated with the ARR (r=.92, p<0.01); (ii) TP informed more than the ARR: while major data departures revealed by the ARR were also detected by TP, TP exhibited patterns not shown by ARR; and (iii) three temporal stages were observed, which differed from one another in both TP and TPMI medians (P<0.01) and, together, revealed a negative relationships between TPMI and TP. The six Latin American countries showed that TP was positively correlated with deaths/million inhabitants or DMI (r=.62, p<0.01). The temporal analysis of policies revealed four patterns: (1) low testing and high DMI, (2) high testing and low DMI; (3) Following the advent of the atypical and severe form of Coronavirus (SARS CoV 2) respiratory infection, which started in Wuhan, China in December 2019, an enormous amount of COVID-19 related data has been generated to date for use by researchers, epidemiologists, public health experts and policy makers globally. Such data may include those of a) confirmed counts, b) rates of cases and deaths, c) symptoms, d) incubation, e) transmission, f) recovered cases, g) critical cases, h) test/million population, among others [1] [2] [3] . However, count data and trends are less useful when consideration is not given to real-time, location-bound evaluations closely aligned to and interpreted alongside an accurate and prompt virus testing [1, 4] . Large epidemiological datasets are useful for insights into disease transmission patterns and trends, measuring the effect of interventions and informing policies for public good but earlier reports have confirmed potential limitation to access quality data, inconsistency in reporting format, scattered data or an overwhelming nature of unorganized data [1] . The 'test positivity rate' (TP) or 'percent positive rate' is the percentage of all coronavirus tests performed that are actually positive, i.e. (positive tests) / (total tests) x 100%. It helps public health officials answer questions such as: 'Are we doing enough testing for the amount of people who are getting infected?' [5] . When the number of positive tests is too high, or the total number of tests is too low number, high test positivity percentage may be found. A higher percent positive may be an indication of a higher transmission and that there are likely more people with coronavirus in the community who have not been tested yet (Dowdy & D'Souza, 2020) . This indicator is critical because it gives us an indication how widespread infection is in the area where the testing is conducted-and whether levels of testing are keeping up with levels of disease transmission. In this work, we explore the test positivity for 11 countries and relate it to other indicators such as the ratio of secondary over primary infections (apparent reproductive ratio or ARR), the tests conducted per million inhabitants (TPM), the temporal shape of the data on the number of active cases (all test-positive cases minus deaths and minus recovered patients), and for the recovered patients. In this regard, test positivity (also known as test positive rate) is the number of cases that can be deduced based on the number of tests conducted over a specified period of time. Granted that well over 50% of the people tested per country were asymptomatic, the credibility of every report generated from countries should be taken with some caution (Taylor, 2020; Oliviera et al., 2021) . This is because no country test more than between 1 and 2% of its population in a day. We therefore made inferences without being sure whether the variables tested are related to real life field observations. Hence, this study is not to tell a success story as data continue to be generated, even after the period covered by the study. It is rather a hypothesis generating study and not a hypothesis testing one. The outcome should therefore be explained with caution as it is not an indictment on any country or government. The essence is to look at several variables, including test positivity, and assess whether this can serve to give some ideas on the nature of epidemics, perhaps at the end of COVID-19 epidemics, these dataset will become more useful and the hypothesis can be tested again. Daily epidemiologic reports were collected from the Uruguayan National System of Emergencies (https://www.gub.uy/sistema-nacional-emergencias/comunicacion/comunicados) (SINAE, report in Spanish) and corroborated with daily reports made by Worldometer (https://www.worldometers.info/coronavirus/). Specifically, daily count data, on: (i) total number of tests conducted in the day, (ii) total number of positives in the day, (iii) total number of hospitalized in Intensive Care Units (at the present day), (iv) total number of active cases (daily and cumulative data), and (v) total number of deaths (daily and cumulative) were obtained. These validated data were subjected to descriptive and analytical statistics using a commercial package (Minitab 19, State College, PA, Minitab Inc,). The measure of central tendencies were obtained through the population medians using the non-parametric statistical procedure, the Mann-Whitney test and plots were generated based on the statistics. For the epidemic data collected in a country affected relatively late in the COVID-19 pandemic -Uruguay− was first considered. One reason supported this selection: control measures could take advantage of the lessons learned in other countries, prior to March 13, 2020 (when the first case was detected) and, specifically, the emphasis this country assigned to achieving a low test positivity could be evaluated. The Apparent Reproductive Rate (ARR) reached 3.65 within three days after the first COVID-19 case was detected in Uruguay (Eppinger and Rueping, 2020). However, once the earliest cases and their contacts were identified, isolated and treated, the ARR rapidly decreased, remaining < 1.1 in the last four weeks of the period under study (Fig. 1A ). An alternative way to monitor the progression of this pandemic is to plot the cumulative number of test-positive individuals (cases), which may include the cumulative number of SARS-CoV2-positive fatalities. This approach revealed an approximately two-week delay in the early growth of both curves (Fig. 1B) . The case and fatality curves showed at least two phases: (i) the earliest one, which displayed a quasi-exponential growth (i.e., the number of cases grew faster than time, which resulted in a quasi-vertical pattern), and (ii) after an inflection, a later, linear phase was observed -in which the growth in the number of cases was slower than time and, therefore, cases exhibited a quasi-horizontal pattern (Fig. 1B) . Hence, the plot that showed case and fatality data revealed profiles not detected, after the first week, in the alternative plot (Figs. 1A, B). New patterns emerged when the daily proportion of all cases treated at Intensive Care Units (ICU) was plotted together with the cumulative number of fatalities. In spite of the difference of scales, ICU cases displayed a pattern similar to that of all cases: both variables grew exponentially -with an approximately one week delay− as long as the cumulative number of cases increased or remained constant. This means that the daily percentage of ICU cases/all cases may be a shortterm predictor of mortality (Fig. 1C) . Relationships between testing and disease-related outcomes were investigated with several approaches. First, the cumulative number of cases was investigated together with the number of tests performed per million inhabitants. Inflections shown by the case and testing data were used to partition each variable into two subsets, which showed 304 cases in the first 14 days (an average of 22.4 cases/day), while 416 cases were reported in the following 32 days (an average of 13 cases/day). The two subsets of cases were associated with less than or more than 2000 tests performed per million inhabitants, respectively. Therefore, a 58 % daily case reduction (13 cases/day in the later period vs. 22.4 cases/day, in the earlier period) was associated with early and massive testing (>2000 tests performed per million people, completed within the first two epidemic weeks). As the number of tests/million people increased even faster in the second period, the number of cases grew slower (vertical lines, Fig. 1D ). Testing and mortality were also analyzed. Because testing is required not only to detect infections but also to assign the cause of deaths, fatalities and testing/million inhabitants were investigated. An inflection shown by the testing data was used to partition the dataset into two subsets. The earlier subset included six fatalities over 10 days (an average of 0.6 deaths/day). In contrast, the later subset reported an average of 0.39 deaths/day. This 35% reduction in fatalities was associated with a level of testing close to 1000 tests/million inhabitants (Fig. 1E ). An alternative analysis focused on the total number of deaths per million inhabitants -an absolute, not a relative metric. Considering an inflection revealed by the deaths-related data, it was found that deaths grew 6.1 times when less than 1000 tests were performed per million inhabitants while mortality increased 2.5 times when more than 1000 tests were conducted per million people (a 2.4 times reduction, Fig. 1F ). While highly correlated (r = 0.96), the fatality rate and the number of deaths/million inhabitants were not identical. Differences in the patterns shown by these metrics helped to confirm or reject the meaning of possible departures. Because the percentage of tests conducted per million inhabitants may be higher or lower at a given day, the number of deaths/million people may remain the same while the fatality rate may appear to differ (Fig. 1G) . For instance, when the fatality rate seemed to decrease, a constant number of deaths/million inhabitants suggested it was not so. The daily test positivity percentage (TP or daily infections detected/all tests performed in a day) helped estimate whether (i) the TP and mortality observed matched expectations, (ii) varied in ways that deserved explanations, and/or (iii) was in line with or differed from the best scenario. After the first two epidemic weeks, the TP remained below 8%, approaching zero in the last two weeks under study. TP included, although exceeded, the information conveyed by the ARR: while the ARR (depicted in Fig. 1A ) revealed a single peak above 1, TP exhibited two trends (above and below 8%) and three peaks or departures below the 8% threshold (Fig. 1H) . Test positivity was inversely correlated with the number of tests performed/million inhabitants ( Fig. 2A) . Furthermore, L-shaped temporal data patterns revealed three stages of decreasing test positivity percentages, which exhibited significantly different medians, inferential test statistics and p-values (Figs. 2B, C) . The shape of data on active cases both corroborated the temporal subsets of data positivity and was more informative than the classic plot on all cases (Fig. 2D ). To determine the external validity of patterns observed in the Uruguayan data, testing and deaths/million inhabitants were investigated, over time, in a group of 11 countries that reported their first case at similar dates. Specifically, Uruguay took advantage of vital time to prepare its hospitals and testing system, conducted massive testing of infected and in-contact persons (tested 233.7 people for every confirmved case of covid-19), produced national testing kit, and ramped up its diagnostic capacity from around 200 tests per day in March to nearly 1000 by the end of May 2020 (Taylor, 2020; supplementary figure 1). Seven of these countries were characterized by either few tests and many deaths or the opposite pattern (Fig. 3A) . However, testing was not the only predictor of deaths/million inhabitants: over time, the country conducting the highest level of testing also reported two-digit deaths/million inhabitants (Fig. 3B) . Test positivity and deaths/million inhabitants differentiated two groups of countries (with low and high TP, respectively). Countries with higher levels of TP were associated, over time, with faster growth of deaths/million inhabitants (red rectangle, Figs. 4 A-D) . The shape of data on active cases further differentiated countries displaying similar (low) levels of mortality: countries revealing a decline in the number of active cases showed the lowest levels of test positivity while those showing no decline but increased numbers expressed higher levels of test positivity (Figs. 5 The ratio between the number of (cumulative) recovered cases divided by the number of active cases (R/A ratio) provided a time-sensitive, valid indicator to monitor epidemics. While it was > 1 throughout the Uruguayan epidemic (Fig. 5A) , it was always < 1 in the Argentinian case (Fig. 5B) . The directionality of the ratio indicated whether recovery grew faster than the number of active cases (ascending, green arrow) or a new outbreak within the epidemic was likely (descending, red arrow, Fig. 5B) . Similar patterns were observed in the Colombian epidemic (Fig. 5C ). In contrast, the Cuban epidemic revealed R/A both below and above 1 (Fig. 5 D) . Relationships among TP, tests/million inhabitants, the shape of Active cases, and the shape of the R/A ratio data supported WHO's recommendations on policies aimed at low TP percentages: high levels of testing (which are likely to detect credible levels of disease prevalence) only occurred at the lowest levels of TP. Such patterns were shown in 3 of the 4 countries investigated and also partially corroborated by the data of remaining country which showed that high TP is associated with a rather low -and, probably, insufficient number of tests/million inhabitants (Figs. 6A-D) . Together with the shape of the number of active cases, TP determined whether and when an epidemic was / was not under control: data inflections of the active cases indicated when the epidemic was about to cease and what level of TP will be associated with the imminent conclusion of the outbreak-especially when the ratio between the number of (cumulative) recovered cases divided by the number of active cases (R/A ratio) was considered− (Figs. 7 A-C) . When TP was analyzed together with tests/million inhabitants, it indicated whether testing was sufficient or not ( Fig. 7 D) . We have evaluated certain epidemic parameters associated with SARS CoV 2 in selected countries. The Apparent Reproductive Rate (ARR) in Uruguay disintegrated rapidly following early detection of the first COVID-19, promptly isolated and treated, an indication that prompt and effective diagnosis is beneficial to mitigate the impact of COVID-19 epidemics. Because the monitoring of the cumulative number of SARS-CoV2-positive fatalities displayed a 2-week delay from cases, early detection provides a better alternative to monitoring of SARS CoV-2 associated fatalities. However, the analysis of the cumulative numbers of cases and fatalities will appear more informative because it revealed clear patterns: the earliest one, which displayed a quasiexponential growth (i.e., the number of cases grew faster than time, which resulted in a quasivertical pattern), and a later one after an inflection, which is a linear phase in which the growth in the number of cases was slower than time -an exhibition of a quasi-horizontal pattern. In this study, there was a positive correlated exponential growth between the patterns of daily proportion of all cases treated at Intensive Care Units (ICU) and cumulative number of fatalities. Hence, it can be inferred that the daily percentage of ICU cases/all cases may be a shortterm predictor of mortality. As the number of tests/million people increased faster, the number of cases grew slower, an indication that increase test positivity rate negatively influence the number of new cases. This was further supported by the fact that when less than 1000 tests were performed per million inhabitants, the number of deaths grew 6.1 times. The L-shaped temporal data patterns revealed three stages of decreasing test positivity percentages, which exhibited significantly different medians, a shape which corroborated the temporal subsets of data positivity of active cases. For practical purpose and to determine the external validity of this pattern, seven of the 11 countries which conducted fewer tests have many more deaths but it should be noted that testing was not the only predictor of deaths/million inhabitants. In addition, countries with higher levels of TP were associated, over time, with faster growth of deaths/million inhabitants. Similarly, countries with the lowest levels of test positivity revealed a decline in the number of active cases. The observed relationships among TP, tests/million inhabitants, the shape of Active cases, and the shape of the R/A ratio data supported WHO's recommendations on policies aimed at low TP percentages: high levels of testing (which are likely to detect credible levels of disease prevalence) only occurred at the lowest levels of TP. The test positivity (TP) together with the shape of the number of active cases, can determine whether and when the epidemic is / is not under control. Associated patterns -such as increasing or decreasing trends of the Recovered/Active ratio data− may inform policy makers whether an overflow of ICU cases is not / is likely in the following weeks. When TP is analyzed together with tests/million inhabitants, it may indicate (in a country-specific manner and without pre-established assumptions) whether testing is sufficient or not. While the data reported here are at nationwide levels, these metrics are also applicable to lower (e.g., state, county, city) geographical scales. Furthermore, Chile did not impose lockdowns but continues to test while not isolating, a strategy that is seen as not enough. In Argentina, there was an imposition of lockdowns but no specific testing scheme. In Mexico, there was neither testing nor lockdowns imposed. We advocated for a mixed policy that focuses on border control and trace-back of every case, which may be more successful, if rapidly implemented (before the exponential growth kicks in), rather than to only focus on lockdowns or testing. Such policy may be complemented by a 'massive' testing and tracking system ('massive' in comparison to what happened in most countries). Such policy has been tested and worked very well for six months before the epidemic fatigue kicked in, and the land borders with Brazil were relaxed and the Manaus strain came in to complicate the situation in the subregion. It is obvious that even if testing is truly massive (today Uruguay tests 0.3 of 1 % of its population each day -that is ~ 75 times more testing/day than one year ago), that may be totally insignificant when the epidemic grows exponentially --that destroys the tracking system. Winning the war against epidemics, and preventing it from becoming endemic, will need a geo- having to wait over two replication cycles of the invading pathogen or 'generation time' before a conclusion can be reached). Because the R0 (or R/t) is the ratio of secondary over primary cases, it is a delayed assessment in which the results are only ready much later (secondary cases), and only then can this be used to calculate the details attributed to the earlier (primary) cases (Yuan et al., 2020) .  Test positivity informed more on cases, mortalities and country-specific patterns than the apparent reproductive ratio and other basic epidemiological concepts.  Test Positivity (usually, lower than 5%) may indicate when the level of testing is adequate and, combined with other indicators, when epidemics are / are not about to cease. A cross-country database of COVID-19 testing WorldOmeter COVID-19 Coronavirus Pandemic: Reported Cases and Deaths by Country, Territory, or Conveyance Accessed at 23 World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard Brusaferro Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy COVID-19 Testing: Understanding the "Percent Positive Monitoring transmissibility and mortality of COVID-19 in Europe Rueping CoVID-19: Where We Are, What We Should Do and Uruguay is winning against COVID-19. This is how Endo Evaluating social distancing measures and their association with the Covid-19 pandemic in South America Authors' Contributions FOF, JBH &ALH conceptualized the idea for the manuscript; FOF, MAS, MMF, OAO, ALH contributed data and materials for analysis; FOF and JBH conducted statistics and contribute to the methodology; All authors contributed to the review of the manuscript for submission. None of the authors has any conflict of interest that should prevent the publication of the manuscript. None of the author below declared any conflict of interest that may prevent the review or publication of this manuscript.